Many of you already know that we operate a website called Stock Traders Talk, which specializes in exclusive executive interviews. Today we have the pleasure of presenting our latest interview, where we hear from SourcingLink.net (SNET) President Chuck Wagner:
Blue Horseshoe Stocks: GILD Options, RCHA & More
Gilead Sciences, Inc. GILD – Options
Our interest in the GILD $97 and $98 Calls which we featured in yesterday’s morning report paid off big-time for us. With GILD breaking the $100-mark, those contracts provided us with ample opportunity to profit.
The $97 Calls went on a major run from a low of 1.15-3.75, an intraday spike of 226%, while the $98’s made a mammoth move from .75-2.65, registering as an impressive 253% romp. Daily charts for both sets of contracts appear on the snapshot below:
GILD will keep our attention as we head into week’s end, we’ll continue to monitor these $97-98 Weeklies, and should it appear that the stock wants to surge higher we may consider rolling up our strike price to the $99-100 Calls.
Rich Pharmaceuticals, Inc. RCHA
For the second day in a row yesterday, the importance of checking our blog daily stood out with another stock off of our Stock Tracker making huge gains. RCHA went on a historical run from super-subpenny (.0009) to .0163, an intraday gain of more than 1700%
We were also talking about RCHA in both our Premium and Free Skype chatrooms*, where members could have gotten in as low as .0019. Plenty of time to attain gains on the order of several hundred percent, as you can see from the following snap of the daily chart on this beast of a play, and the message from the chatroom at 9:53am.
Today, we would expect to see a gap-up followed by a significant dip as profit-takers exit their positions. From there, if properly timed, we could be looking at a big bounceplay, so we’ll want to keep RCHA on watch for at least the remainder of the week.
*Any readers who’d like to be involved in these trading chats in the future can do so easily! For either the Premium or the free chats, simply add “stocksumo” as a contact on Skype to request access!
Extended Watchlist (All Earnings Plays):
UA, GMCR, DATA
Blue Horseshoe Stocks: New Options Trading Ideas
Gilead Sciences, Inc. GILD
& Chipotle Mexican Grill, Inc. CMG – Options Ideas
We see potential opportunities in the options arena this mid-week, from a couple of stocks that we’re catching on the heels of their earnings calls. Despite earnings beats for both, each stock has actually fallen.
Gilead Sciences, Inc. GILD – Despite exceptional 2014 earnings, investors read between the lines on a number of other key aspects following last nights call, and as a result the stock is taking a bit of a beating. This morning’s premarket low stands at 90.60. That will be the price-point we’ll need to monitor to determine an options trading strategy. Should GILD sustain a recovery off of these lows, we’ll be looking at in-the-money Calls, most likely at the $97 and $98 levels. In the event that the stock begins to find new lows we’d need to flip our strategy to Put side of the fence.
Chipotle Mexican Grill, Inc. CMG – Here we have a similar situation, with CMG taking a beating in today’s premarket, having hit a low of $675. Like GILD, earnings expectations were exceeded, however shortcomings in sales and other key metrics has momentarily taken the wind out of CMG’s sails. This is another situation where we need to monitor the stock to ensure it doesn’t fall below the premarket low in order to secure our interest in playing the Calls. We’d obviously need to look at Puts if CMG were to backslide any further, but barring that occurrence, were going to be looking at Calls in the $675-$680 range.
Inergetics, Inc. NRTI
NRTI serves as a reminder of why it’s always a good idea to check our blog at Blue Horseshoe Stocks each morning even if you’ve consumed our report via email or elsewhere. The contents of our daily-updated Stock Tracker may or may not be included in that day’s report, and often those stocks we add at the last minute go on to provide big opportunities.
That was the case with NRTI yesterday; we placed it on the tracklist just minutes prior to the opening bell, and the stock made one heck of a move. From a low of .0115, it went on to touch a daily high of .02, marking a healthy intraday move of 74% on just over three times the 30-day average volume.
Extended Watchlist:
AAPT, BABB, DIS, GPRO(Earnings Tomorrow Post-Market)
Blue Horseshoe Stocks: PZOO Rehash
Pazoo, Inc. PZOO – Updates
Readers who have been following our reports at least since November will remember our talking about this stock, and since that time there have been several developments with Pazoo. For that reason we will be taking another look at PZOO this morning, reviewing those updates the company has sent over the wires in the past several weeks.
When we first began tracking this play in the fall, the company had just begun to explore opportunities in the cannabis sector, and it has shown dedication to that goal by making significant progress in that area in recent months through its partly-owned partner, as well as a new wholly-owned subsidiary.
Nevada cannabis testing firm MA & Associates, in which PZOO holds a 40% interest, on December 11th announced the first purchase order of product testing from one of the state’s largest licensed growers, tentatively set to begin at the end of this month. >> VIEW PR
A week later, it was revealed that the agency had entered into another agreement to provide exclusive testing on all of their marijuana grown for the next two years. It will begin with 100,000 square feet of ‘grow’ (An estimated contract value of $1M/year) with the intention of expanding up to 875,000 sq.ft. of in the next two years. >> VIEW PR
In another more recent development related to its expansion into the cannabis sector, PZOO added Harris Lee, LLC as a 100% Wholly-Owned Subsidiary which is also operates in the niche business of medical marijuana testing. >> View PR
*In addition to its growing involvement in the medical marijuana space, Pazoo still operates its health & wellness web portal and store at PAZOO.COM. Its accompanying podcast, Pazoo Radio, is now up to its 9th episode, and includes a wide range of topics along and special guests >> GO TO PAZOO RADIO
PZOO CHART:
As a quick glance at the chart will show, it appears to be a good time to turn our focus to PZOO again from a technical standpoint as well. Lately, we’ve had quite a bit of good fortune relating to bottom plays rebounding off of their 52-week lows, and that’s precisely the position in which we now find this stock. We’ll initially be looking for PZOO to challenge primary resistance at the 50DMA of .0183.
We also want to highlight this morning’s PR regarding new members of management joining the team to help facilitate PZOO’s aggressively planned expansion into the marijuana testing business:
WHIPPANY, N.J., Feb. 3, 2015 (GLOBE NEWSWIRE) — Pazoo, Inc. (PZOO) (German WKN#: A1J3DK) is pleased to announce Antonio Del Hierro and David Lieberthal, Esq. have been nominated to its Board of Directors. >> FULL PR
More Information @ PAZOO.COM
Blue Horseshoe Stocks: Refocusing on ACGX
Alliance Creative Group, Inc. ACGX – Update
All but the newest of our readers should be aware of our ongoing interest in ACGX. The stock has appeared in our reports on several occasions over the past couple of years, and it has repeatedly provided us with chances to turn a profit.
This past spring, we tracked ACGX on its way to a 100% move from .0055-.011. Upon subsequent consolidation, we also witnessed many significant swings. Most recently, we focused on ACGX a couple of weeks ago on January 15th. The stock had come down to bounce off of support at the .002-level, and that report turned out to be very well-timed, with the session yielding up a 33% intraday run from .0021 to .0028.
What we’d like to do today before assessing the current positioning of the ACGX chart, is to focus a bit more on the company’s latest acquisition, PeopleVine:
PeopleVine is a complete customer relations platform comprised of an impressive suite of tools that facilitate every aspect of customer engagement for growing businesses.
From identifying, targeting, and acquiring new customers, to managing existing ones and keeping them actively engaged and loyal, Peoplevine’s individual modules are seamlessly integrated from start to finish. It effectively replaces multiple avenues of customer engagement, and therefore has the potential to reduce costs in those areas.
The platform provides economic efficiency by breaking down each customer interaction to individual events called TouchPoints. The pricing structure is divided into multiple levels for scalability, so companies aren’t paying for more than they need to effectively grow their business.
We’re really impressed with the capabilities of the PeopleVine platform and its overall flexibility, and most importantly, the added value its acquisition brings to ACGX. You can take a much closer look over at the PeopleVine product page.
CHART:
We’ve prepared a video presentation of the ACGX Chart that we’d like you to check out by clicking the graphic below.
As the video states, we want to see support hold for ACGX at or above the .0018-.002 range. Resistance is sitting in the channel between .0027-.0029 channel so we’ll be looking for a break through that area, where the next target would be the 200DMA of .0035. A return to that point on the chart would spell potential gains in excess of 75% So we’ll continue to devote attention to ACGX, which has yet to let us down over our long history with the stock.
More Info @ AllianceCreativeGroup.com
Side Note – AMZN Options Success:
We want to take a quick moment to highlight some absolutely amazing Options Calls we made on AMZN last week. We scored our first 1000% gainer with NFLX Options the week prior, and it didn’t take us very long to identify a couple more!
On Friday, we highlighted the weekly $345 and $350 Calls for intraday flip opportunities and what we ended up with were some ridiculously large gains. The $345 Calls traded from a low of 1.15 and shot all the way up to 14.25, marking a single session move of 1139% The $350’s fared even better, registering a run from .39 to 9.56, a mind boggling 2351%
Congratulations to anyone who was following our AMZN calls on Friday. We’ve had immense success with options trading thus far this year, and vow to continue the trend as best we can! The biggest gains are yet to come!